Observation of Alectinib‐ and Crizotinib‐ included chemotherapy in children with ALK‐positive anaplastic large cell lymphoma: A single institutional experience

Approximately one‐third children with anaplastic large cell lymphoma (ALCL) relapse after completion of chemotherapy, particularly for those high‐risk patients. The introduction of novel therapeutic modalities is much needed for these sub‐group patients. Two groups (n = 3, n = 4) of ALCL patients we...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Yingyi, Pei, Kunlin, Zhang, Hui, Wang, Jiayi, Su, Xiaoling, Gan, Wenting, Wang, Pengfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
BRIEF COMMUNICATION
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067055/
https://www.ncbi.nlm.nih.gov/pubmed/36408869
http://dx.doi.org/10.1002/cam4.5479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067055/
https://www.ncbi.nlm.nih.gov/pubmed/36408869
http://dx.doi.org/10.1002/cam4.5479

Ejemplares similares